Palvella Therapeutics, Inc. (PVLA)
146.15
-5.43
(-3.58%)
USD |
NASDAQ |
Oct 30, 16:00
145.98
-0.17
(-0.12%)
After-Hours: 20:00
Palvella Therapeutics Market Cap : 2.104B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.104B |
| October 29, 2026 | 2.182B |
| October 28, 2026 | 2.123B |
| October 27, 2026 | 1.913B |
| October 26, 2026 | 1.817B |
| October 23, 2026 | 1.801B |
| October 22, 2026 | 1.819B |
| October 21, 2026 | 1.822B |
| October 20, 2026 | 1.784B |
| October 19, 2026 | 1.770B |
| October 16, 2026 | 1.732B |
| October 15, 2026 | 1.833B |
| October 14, 2026 | 1.765B |
| October 13, 2026 | 1.850B |
| October 12, 2026 | 1.934B |
| October 09, 2026 | 1.998B |
| October 08, 2026 | 1.891B |
| October 07, 2026 | 1.880B |
| October 06, 2026 | 1.843B |
| October 05, 2026 | 1.903B |
| October 02, 2026 | 1.907B |
| October 01, 2026 | 1.911B |
| September 30, 2026 | 1.986B |
| September 29, 2026 | 2.001B |
| September 28, 2026 | 2.013B |
| Date | Value |
|---|---|
| September 25, 2026 | 1.989B |
| September 24, 2026 | 2.103B |
| September 23, 2026 | 2.153B |
| September 22, 2026 | 2.276B |
| September 21, 2026 | 2.208B |
| September 18, 2026 | 2.167B |
| September 17, 2026 | 2.222B |
| September 16, 2026 | 2.180B |
| September 15, 2026 | 2.177B |
| September 14, 2026 | 2.184B |
| September 11, 2026 | 2.161B |
| September 10, 2026 | 2.165B |
| September 09, 2026 | 2.179B |
| September 08, 2026 | 2.192B |
| September 04, 2026 | 2.264B |
| September 03, 2026 | 2.238B |
| September 02, 2026 | 2.202B |
| September 01, 2026 | 2.167B |
| August 31, 2026 | 2.197B |
| August 28, 2026 | 2.159B |
| August 27, 2026 | 2.164B |
| August 26, 2026 | 2.222B |
| August 25, 2026 | 2.134B |
| August 24, 2026 | 2.098B |
| August 21, 2026 | 2.045B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcus Biosciences, Inc. | 2.310B |
| Design Therapeutics, Inc. | 668.36M |
| Agenus, Inc. | 291.49M |
| Amgen, Inc. | 251.93B |
| Anika Therapeutics, Inc. | 280.37M |
Market Cap Related Metrics
| Price to Book Value | 9.702 |
| Price | 146.15 |
| Earnings Yield | -3.31% |